Womens Imaging: Page 170

Seno Medical points to research at RSNA 2018

By AuntMinnie.com staff writers

Optoacoustic imaging firm Seno Medical Instruments is directing attention to results from a clinical trial of its optoacoustic technology that were presented at the recent RSNA 2018 meeting in Chicago.

December 10, 2018

Breast cancer risk persists decades after childbirth

By AuntMinnie.com staff writers

Women's risk of breast cancer can persist more than 20 years after childbirth, according to a study published online December 10 in the Annals of Internal Medicine.

December 10, 2018

Canadian guidelines recommend against early mammography

By Kate Madden Yee

The Canadian Task Force on Preventive Health Care has released breast cancer screening guidelines that recommend against screening in women between the ages of 40 and 49.

December 9, 2018

Cianna touts SAVI Scout results at SABCS

By AuntMinnie.com staff writers

At this week's San Antonio Breast Cancer Symposium (SABCS), breast tumor localization technology provider Cianna Medical is highlighting preliminary data documenting the safe use of its SAVI Scout to localize axillary lymph nodes before starting chemotherapy treatment.

December 9, 2018

Black women have worse breast cancer outcomes

By Kate Madden Yee

Black women have higher breast cancer recurrence and overall mortality compared with their white counterparts, even when they receive equivalent treatments, according to research presented at the 2018 San Antonio Breast Cancer Symposium.

December 9, 2018

PET tracers help guide breast cancer therapies

By Kate Madden Yee

PET imaging tracers that track breast cancer enzymes could help guide treatment of the disease, especially in women with BRCA mutations and triple-negative subtypes of cancer, according to two studies presented this week at the 2018 San Antonio Breast Cancer Symposium.

December 6, 2018

iCAD gets FDA nod for ProFound AI software for DBT

By AuntMinnie.com staff writers

iCAD has received U.S. Food and Drug Administration (FDA) clearance for its ProFound AI artificial intelligence (AI) software for analyzing digital breast tomosynthesis (DBT) studies.

December 6, 2018

TOF PET/MRI makes dose reduction viable for breast cancer

By Wayne Forrest

Can clinicians use as little as 10% of the conventional FDG dose and still produce diagnostic-quality images to detect breast cancer? Absolutely. It's feasible using a time-of-flight (TOF) imaging technique with PET/MRI, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 6, 2018

DBT betters mammo performance in screening, diagnosis

By Kate Madden Yee

Digital breast tomosynthesis (DBT) improves upon mammography's performance in both screening and diagnostic settings, according to a pair of studies presented at the recent RSNA annual meeting in Chicago.

December 5, 2018

Ultrasound after DBT obviates diagnostic 2D mammo

By Kate Madden Yee

Performing a diagnostic mammogram to assess suspicious masses found on digital breast tomosynthesis (DBT) may not be necessary if ultrasound is available, according to a new study published online on November 29 in the British Journal of Radiology. Researchers found that ultrasound is 98% effective for further assessing masses found on DBT screening exams.

December 4, 2018

Hologic wins ruling against ex-employee, Chinese firm

By AuntMinnie.com staff writers

Women's imaging firm Hologic has been granted a preliminary injunction from a Commonwealth of Massachusetts court in its civil litigation against a former employee and Chinese x-ray equipment provider Direct Digital Imaging Technology.

November 29, 2018

ScreenPoint partners with Volpara

By AuntMinnie.com staff writers

Dutch women's imaging software developer ScreenPoint Medical has signed a memorandum of understanding with breast imaging software developer Volpara Solutions.

November 28, 2018

Previous Page

Page 170 of 692

Next Page